Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 236-240

  Song, Sang Hyun ^a   Jong, Hyun Soon ^a   Choi, Hyun Ho ^a   Kang, Shin Hyeok ^a   Ryu, Min Hee ^a   Kim, Noe Kyeong ^a   Kim, Woo Ho ^a   Bang, Yung Jue ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA DETERMINATION; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARRIER PROTEINS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MODELS, GENETIC; MUTAGENS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; SULFITES; TUMOR CELLS, CULTURED;

EID: 0034662110     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<236::AID-IJC14>3.0.CO;2-M     Document Type: Article

References (19)

1. CAIRNS, P., MAO, L., MERLO, A., LEE, D.J., SCHWAB, D., EBY, Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16(MTSI) mutations in primary tumors with 9p loss. Science, 265, 415-416 (1994).
2. COSTELLO, J.F., BERGER, M.S., HUANG, H.-J.S. and CAVENEE, W.K., Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res., 56, 2405-2410 (1996).
3. FROMMER, M., MCDONALD, L.E. MILLAR, D.S., COLLIS, C.M., WATT, F., GRIGG, G.W., MOLLY, P.L. and PAUL, C.L., A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. nat. Acad. Sci. (Wash.), 89, 1827-1831 (1992).
4. GONZALEZ-ZULUETA, M., BENDER, C.M., YANG, A.S., NGUYEN, T., BEART, R.W., VAN TORNOUT, J.M. and JONES, P.A., Methylation of the 5′ CpG island of the p16/CDKN2 tumor-suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
5. GONZALGO, M.L., HAYASHIDA, T., BENDER, C.M., PAO, M.M., TSAI, Y., GONZALES, F.A., NGUYEN, H.D., NGUYEN, T.T. and JONES, P.A., The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res., 58, 1245-1252 (1998).
6. HAYASHI, K., METZGER, R., SALONGA, D., DANENBERG, K., LEICHMAN, L.P., FINK, U., SENDLER, A., KELSEN, D., SCHWARTZ, G.K., GROSHEN, S., LENZ, H.J. and DANENBERG, P.V., High frequency of simultaneous loss of p16- and p16beta-gene expression in squamous-cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene, 15, 1481-1488 (1997).
7. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
8. IGAKI, H., SASAKI, H., TACHIMORI, Y., KATO, H., WATANABE, H., KIMURA, T., HARADA, Y., SUGIMURA, T. and TERADA, M., Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55, 3421-3423 (1995).
9. JONG, H.-S., PARK, Y.I., KIM, S., SOHN, J.H., KANG, S.H., SONG, S.H., BANG, Y-J. and KIM, N.K., Up-regulation of human telomerase catalytic sub-unit during gastric carcinogenesis. Cancer, 86, 559-565 (1999).
10. LEE, Y.Y., KANG, S.H., SEO, J.Y., JUNG, C.W., LEE, K.U., CHOE, K.J., KIM, B.K., KIM, N.K., KOEFFLER, H.P. and BANG, Y-J., Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer, 80, 1889-1896 (1997).
11. LIEW, C.T. and 12 OTHERS, High frequency of p16INK4A-gene alterations in hepatocellular carcinoma. Oncogene, 18, 789-795 (1999).
12. MAO, L., MERLO, A., BEDI, G., SHAPIRO, G.I., EDWARDS, C.D., ROLLINS, B.J. and SIDRANSKY, D., A novel p16INK4A transcript. Cancer Res., 55, 2995-2999 (1995).
13. MATSUDA, Y., ICHIDA, T., MATSUZAWA, J., SUGIMURA, K. and ASAKURA, H., p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology, 116, 394-400 (1999).
14. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/ MTS1 in human cancers. Nature Med., 1, 686-692 (1995).
15. REED, A.L., CALIFANO, J., CAIRNS, P., WESTRA, W.H., JONES, R.M., KOCH, W., AHRENDT, S., EBY, Y., SEWELL, D., NAWROZ, H., BARTEK, J. and SIDRANSKY, D., High frequency of p16(CDKN2/MTS-I/INK4A) inactivation in head- and-neck squamous-cell carcinoma. Cancer Res., 56, 3630-3633 (1996).
16. ROBERTSON, K.D. and JONES, P.A., The human ARF cell-cycle-regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. cell. Biol., 18, 6457-6473 (1998).
17. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
18. TIMMERMANN, S., HINDS, P.W. and MUNGER, K., Re-expression of endogenous p16ink4a in oral-squamous-cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state. Oncogene, 17, 3445-3453 (1998).
19. WU, M.S., SHUN, C.T., SHEU, J.C., WANG, H.P., WANG, J.T., LEE, W.J., CHEN, C.J., WANG, T.H. and LIN, J.T., Over-expression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological sub-types and stages. J. Gastroenterol. Hepatol., 13, 305-310 (1998).